- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Leukemia, Myeloid
Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Myeloid
Total 263 results
-
Stéphanie Nguyen, MDSeen in:
- Paris, Hôpital de la Pitié-Salpétrière
Trials:- NCT03439371 (Principal Investigator)
Conditions: -
Sylvain ChantepieSeen in:
- Caen, CHU de Caen
- Caen, Institut d'hématologie de Basse Normandie (IHBN)
Trials:- NCT05260528 (Principal Investigator)
- NCT03450512 (Principal Investigator)
Conditions: -
Sylvain Garciaz, Dr.Seen in:
- Marseille, Institute Paoli-Calmettes
Trials:- NCT04086264 (Principal Investigator)
Conditions: -
T. CluzeauSeen in:
- Nice, FR-Nice-LARCHET
Trials:- NCT04027309 (Principal Investigator)
-
Thierry MURONSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT05130138 (Sub-Investigator)
Conditions: -
Thierry Takam, MDSeen in:
- Provence-Alpes-Côte d'Azur, Avignon, Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Trials:- NCT06082804 (Sub-Investigator)
Conditions: -
Thomas BACHELOTSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
-
Thomas CluzeauSeen in:
- Nice, Archet 1 Hospital
- Nice, CHU de Nice
- Nice, CHU de Nice - Hopital De L'Archet
- Nice, CHU de Nice - Hopital L'Archet
- Nice, CHU de Nice - Hôpital Archet 1
- Nice, Hôpital Archet 1/Service d'Hématologie Clinique
- Nice, Hôpital l'Archet- CHU de Nice
Trials:- NCT04797780 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT03643042 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT01210274 (Principal Investigator)
- NCT03829072 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05181735 (Principal Investigator)
- NCT06030089 (Principal Investigator)
-
Thorsten BraunSeen in:
- Bobigny, FR-Bobigny-AVICENNE
- Bobigny, Hôpital Avicenne
- Bobigny, Hôpital Avicenne APHP
Trials:- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
Valérie COITEUX, MDSeen in:
- Lille, CHRU Lille
- Lille, CHRU de Lille
- Lille, CHU Lille
Trials:- NCT03481868 (Principal Investigator)
- NCT06130787 (Principal Investigator)
- NCT03439371 (Sub-Investigator)
-
Vanessa PANTE, MDSeen in:
- Le Puy-en-Velay, Centre Hospitalier Emile ROUX
Trials:- NCT06130787 (Principal Investigator)
- NCT05963061 (Sub-Investigator)
Conditions: -
Victoria CACHEUX, MDSeen in:
- Clermont-Ferrand, CHU Estaing
- Clermont-Ferrand, Chu Cth Estaing Clermont Ferrand
Trials:- NCT03439371 (Sub-Investigator)
- NCT04384341 (Sub-Investigator)
Conditions: -
Violette MESDAGSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Waisse WAISSISeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Xavier THOMAS, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud, Hematology department
Trials:- NCT03796533 (Sub-Investigator)
Conditions: -
Y. DesbrossesSeen in:
- Besançon, FR-Besançon Cedex-JEANMINJOZ
Trials:- NCT04027309 (Principal Investigator)
-
Yann GUILLERMINSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
Conditions:- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC
-
Yohan DesbrossesSeen in:
- Besançon, CHRU Jean Minjoz
Trials:- NCT05260528 (Principal Investigator)
Conditions:
Clinical Trials on Leukemia, Myeloid
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Peking University People's HospitalBeijing JD Biotech Co. LTD.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina
-
Xuzhou Medical UniversityRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Yale UniversityPfizerTerminatedACUTE MYELOID LEUKEMIAUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States